Cargando…
Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma
BACKGROUND: Colorectal carcinoma (CRC) is the third most common cancer in the world and also the third leading cause of cancer-related mortality in Taiwan. CRC tumorigenesis is a multistep process, starting from mutations causing loss of function of tumor suppressor genes, canonically demonstrated i...
Autores principales: | Bui, Vo-Minh-Hoang, Mettling, Clément, Jou, Jonathan, Sun, H. Sunny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579792/ https://www.ncbi.nlm.nih.gov/pubmed/33087131 http://dx.doi.org/10.1186/s12920-020-00776-z |
Ejemplares similares
-
Duplications at 19q13.33 in patients with neurodevelopmental disorders
por: Pérez-Palma, Eduardo, et al.
Publicado: (2018) -
Somatic Mutational Landscape in Mexican Patients: CDH1 Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma
por: Cerrato-Izaguirre, Dennis, et al.
Publicado: (2022) -
19q13.33→qter trisomy in a girl with intellectual impairment and seizures
por: Carvalheira, Gianna, et al.
Publicado: (2014) -
A Genotype-First Approach for the Molecular and Clinical Characterization of Uncommon De Novo Microdeletion of 20q13.33
por: Traylor, Ryan N., et al.
Publicado: (2010) -
Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels
por: Parikh, Hemang, et al.
Publicado: (2011)